← FDA Drug Approvals (Drugs@FDA)

LAMIVUDINE; ZIDOVUDINE

NDA · New Drug Application · Sponsor: CIPLA LIMITED · Approved 2012-06-15

Drug application

FDA Application #

NDA202814

Application type

New Drug Application

Brand name

LAMIVUDINE; ZIDOVUDINE

Generic name

Lamivudine

Active ingredients

LAMIVUDINE; ZIDOVUDINE

Dosage form

TABLET, FOR SUSPENSION

Route

ORAL

Marketing status

None (Tentative Approval)

Sponsor

CIPLA LIMITED

First approval

2012-06-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown